VanEck Pharmaceutical ETF
PPH
#1050
ETF rank
HK$10.29 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
HK$792.35
Share price
0.32%
Change (1 day)
11.98%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of March 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of March 2026: 0.36%